Mpm Asset Management LLC insider trades: Aktis Oncology (AKTS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mpm Asset Management LLC reports to the SEC






and 1 more company
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | AKTS | ↑ Buy | 1,112,777 | $18.00 | $20.0M | Indirect | Jan 14, 2026 (2d) |
| Dec 4, 2025 | HOWL | ↓ Sell | 199,732 | $0.92 | $183K | Indirect | Dec 4, 2025 (0d) |
| Dec 1, 2025 | HOWL | ↓ Sell | 141,927 | $0.96 | $137K | Indirect | Dec 1, 2025 (0d) |
| Nov 25, 2025 | HOWL | ↓ Sell | 195,666 | $0.92 | $180K | Indirect | Nov 25, 2025 (0d) |
| Nov 20, 2025 | HOWL | ↓ Sell | 160,103 | $0.92 | $148K | Indirect | Nov 20, 2025 (0d) |
| Nov 17, 2025 | HOWL | ↓ Sell | 209,652 | $0.96 | $201K | Indirect | Nov 17, 2025 (0d) |
| Nov 12, 2025 | HOWL | ↓ Sell | 213,529 | $1.13 | $241K | Indirect | Nov 12, 2025 (0d) |
| Nov 6, 2025 | HOWL | ↓ Sell | 242,890 | $1.22 | $296K | Indirect | Nov 6, 2025 (0d) |
| Nov 3, 2025 | HOWL | ↓ Sell | 295,043 | $1.33 | $392K | Indirect | Nov 3, 2025 (0d) |
| Oct 29, 2025 | HOWL | ↓ Sell | 276,017 | $1.62 | $446K | Indirect | Oct 29, 2025 (0d) |
| Mar 27, 2025 | HOWL | ↓ Sell | 4,386 | $1.05 | $5K | Indirect | Apr 30, 2025 (34d) |
| May 22, 2023 | TCRR | ↓ Sell | 70,170 | $1.88 | $132K | Direct | May 24, 2023 (2d) |
| Apr 15, 2021 | HARP | ↓ Sell | 4,666 | $20.16 | $94K | Indirect | Apr 15, 2021 (0d) |
| Apr 12, 2021 | HARP | ↓ Sell | 12,796 | $23.15 | $296K | Indirect | Apr 13, 2021 (1d) |
| Feb 10, 2021 | HARP | ↓ Sell | 183,051 | $20.00 | $3.7M | Indirect | Feb 12, 2021 (2d) |
| Feb 9, 2021 | HARP | ↓ Sell | 91,700 | $20.06 | $1.8M | Indirect | Feb 9, 2021 (0d) |
| Feb 4, 2021 | HARP | ↓ Sell | 120,073 | $20.22 | $2.4M | Indirect | Feb 4, 2021 (0d) |
| Jan 27, 2021 | HARP | ↓ Sell | 721,194 | $20.02 | $14.4M | Indirect | Jan 27, 2021 (0d) |
| Jan 22, 2021 | HARP | ↓ Sell | 68,455 | $22.51 | $1.5M | Indirect | Jan 22, 2021 (0d) |
| Oct 6, 2020 | ONCR | ↑ Buy | 173,776 | $15.00 | $2.6M | Indirect | Oct 8, 2020 (2d) |
| Feb 19, 2019 | TCRR | ↑ Buy | 706,666 | $15.00 | $10.6M | Indirect | Feb 21, 2019 (2d) |
| Feb 12, 2019 | HARP | ↑ Buy | 250,000 | $14.00 | $3.5M | Indirect | Feb 14, 2019 (2d) |
| Feb 12, 2019 | HARP | ↓ Sell | 1,524 | $14.00 | $21K | Indirect | Feb 14, 2019 (2d) |
| Oct 27, 2011 | ZLCS | ↓ Sell | 738,807 | $1.03 | $761K | Indirect | Oct 28, 2011 (1d) |
| Oct 26, 2011 | ZLCS | ↓ Sell | 281,200 | $1.02 | $287K | Indirect | Oct 27, 2011 (1d) |
| Oct 24, 2011 | ZLCS | ↓ Sell | 322,100 | $1.03 | $331K | Indirect | Oct 25, 2011 (1d) |
| Oct 20, 2011 | ZLCS | ↓ Sell | 459,817 | $1.03 | $473K | Indirect | Oct 21, 2011 (1d) |
| Oct 17, 2011 | ZLCS | ↓ Sell | 19,644 | $1.02 | $20K | Indirect | Oct 19, 2011 (2d) |
| Oct 14, 2011 | ZLCS | ↓ Sell | 44,700 | $1.02 | $46K | Indirect | Oct 17, 2011 (3d) |
| Oct 12, 2011 | ZLCS | ↓ Sell | 338,300 | $40.36 | $13.7M | Indirect | Oct 13, 2011 (1d) |
| Oct 10, 2011 | ZLCS | ↓ Sell | 505,200 | $1.03 | $523K | Indirect | Oct 11, 2011 (1d) |
| Oct 6, 2011 | ZLCS | ↓ Sell | 380,232 | $1.02 | $388K | Indirect | Oct 6, 2011 (0d) |
| Sep 27, 2011 | ZLCS | ↓ Sell | 410,000 | $1.10 | $451K | Indirect | Sep 28, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AKTS insiders
Open-market trades in the last 12 months
About Mpm Asset Management LLC's insider trades
Mpm Asset Management LLC is a 10% owner of Aktis Oncology (AKTS). Since Sep 27, 2011, it has reported 4 open-market purchases worth $36.7M and 29 sales worth $43.6M on SEC Form 4. In the last 12 months: 1 buy ($20.0M) and 6 sales ($1.1M).
Its filings also include conversions (4 filings), option exercises (3 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKTS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.